Most Read News


MOHW’s administrative measures will gain momentum on ‘Novartis’ rebate case’

The Novartis’ rebate case, which has been paused for a moment, will be accelerated by the Ministry of Health and Welfare(MOHW) in administrative disposition. According to the MOHW on the 27th, the ministry will annou...

MSIP to sponsor new drug development up to non-clinical study with KRW 500 billion within 10 years

The government has attracted the industry as planning to carry out a project to support new drug development up to the non-clinical study phase with KRW 500 billion within 10 years. Deputy Director Nam-Gyu Cho at the...

MOHW starts to prepare for General Development Plans for Secondary Pharma Industry

The Ministry of Health and Welfare(MOHW) will start to prepare for the Mid/Long-term General Plans for Secondary Health and Medical R&D. The MOHW held the 5th ‘Public-Private Council for Promotion of Bio-health Indus...

Will distribution industry’s suggestions be reflected to enforcement of serial number system?

Even though enforcement of the serial number system for pharmaceutical distribution companies has created issues, it will still be implemented this July. Thus, the industry has paid attention to whether the government...

Pharmas hesitated in developing generics, showing decrease in bioequivalently-tested drugs

It was observed there were only 96 pharmaceutical products approved through bioequivalence test this year. This is because pharmaceutical companies are hesitated in developing generic products. According to the Minis...

Bloody competition among bioequivalence test service organizations causes shutdown of business

Due to fierce competition among service organizations for bioequivalence test, one of them decided to shut down business. Korea Pharmaceutical Test & Research Institute, an agency of the Korea Pharmaceutical Traders ...

Patients society urges health insurance benefits for terminal lung cancer therapy

On the 6th, the Korea Alliance of Patients Organization(hereinafter referring to KAPO) announced a statement to urge prompt application of the health insurance benefits for terminal lung cancer therapies. The Health ...

What are the government’s plans for investment into new drug in 2018?

The government is planning to enlarge support for new drug development in the initial phase, reduce the support in the commercialization phase, like Phase 3 clinical trials, and promote investments into private compan...

Distribution companies required to get consent forms to use personnel information

It was criticized pharmaceutical distribution companies need to be cautious since they might provide information against the Personnel Information Protection Law when providing information about drug sales to pharmace...

Chronic kidney patients with abdominal obesity have double chance of getting cardiovascular disease

In order to celebrate the World Kidney Day on the 9th, the Korea Centers for Disease Control and Prevention(Director Jung-Ki Suck) announced a research report that abdominal obesity patients have the highest chance of...

National Assembly’s debate for adjustment of household drugs at convenient stores

While the government has created an issue as trying to adjust the number of emergency household products, it will conduct debates related to it. The National Assembly Health and Welfare Committee’s Rep. Do-Ja Choi(Pe...

Kyowa Kakko Kirin signs license agreement of hyperphosphatemia treatment ‘Nephoxil’

Kyowa Hakko Kirin Korea(CEO Shigeaki Suzuki) announced a license agreement of the hyperphosphatemia treatment ‘Nephoxil’ with Taiwanese Panion & BF Biotech on the 20th of February. Hyperphosphatemia is a symptom in w...

MFDS to become member of ‘International Medical Device Regulators Forum(IMDRF)’

In order to join in the International Medical Device Regulators Forum(IMDRF) which harmonizes the international medical device regulations of each country, the Ministry of Food and Drug Safety(MFDS) will attend the 11...

Pharmas vs Distribution over price and margins in distribution market

In order to resolve problems, such as margin cuts and competition against each company, pharmaceutical distribution companies are working on strengthening competitiveness through various ways, like enlargement and spe...

Will water-leaking Korean Pharmaceutical Association Bldg. be discussed for reconstruction?

The issue of reconstructing Korean Pharmaceutical Association Bldg. has been raised again. The industry has shown interests if the issue will be voted by the members in favor of the reconstruction. The members have a...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.